%D9%85%D8%A7%D8%B1%D9%8A%D8%A7_%D9%81%D8%A7%D9%86_%D9%83%D9%8A%D8%B1%D9%88%D9%81Maria_Van_KerkhoveCategory:Maria_Van_KerkhoveMaria_Van_KerkhoveMaria_Van_KerkhoveMaria_Van_KerkhoveMaria_Van_Kerkhove%E0%B4%AE%E0%B4%B0%E0%B4%BF%E0%B4%AF_%E0%B4%B5%E0%B4%BE%E0%B5%BB_%E0%B4%95%E0%B5%86%E0%B5%BC%E0%B4%95%E0%B5%8B%E0%B4%B5%E0%B5%8D%D0%92%D0%B0%D0%BD_%D0%9A%D0%B5%D1%80%D0%BA%D1%85%D0%BE%D0%B2%D0%B5,_%D0%9C%D0%B0%D1%80%D0%B8%D1%8FQ28025108
about
Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling studyAssociation between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective studyPandemic potential of a strain of influenza A (H1N1): early findingsEvaluation of exposure to arsenic in residential soilPotential Biases in Estimating Absolute and Relative Case-Fatality Risks during OutbreaksHarmonisation of Zika virus research protocols to address key public health concerns.Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projectionsMultiple contributory factors to the age distribution of disease cases: a modeling study in the context of influenza A(H3N2v)Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational StudyYellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological dataSchool closures during the 2009 influenza pandemic: national and local experiencesMiddle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibilityEstimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.Key data for outbreak evaluation: building on the Ebola experience.Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013–2016Middle East Respiratory Syndrome.Incidence of influenza A(H1N1)pdm09 infection, United Kingdom, 2009-2011.CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic reviewRisk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysisTransmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 Southern hemisphere countries.Epidemic and intervention modelling--a scientific rationale for policy decisions? Lessons from the 2009 influenza pandemic.Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Influenza-related deaths--available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe.The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy.Worldwide transmission and seasonal variation of pandemic influenza A(H1N1)2009 virus activity during the 2009-2010 pandemic.Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008Changes in poultry handling behavior and poultry mortality reporting among rural Cambodians in areas affected by HPAI/H5N1.Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocolsEbola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned.Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart.Estimating Potential Incidence of MERS-CoV Associated with Hajj Pilgrims to Saudi Arabia, 2014Distinguishing Between Reservoir Exposure and Human-to-Human Transmission for Emerging Pathogens Using Case Onset DataWest African Ebola epidemic after one year--slowing but not yet under control.Ebola virus disease among children in West Africa.A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-makingImpact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis.International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISEEnvironmental contamination and risk factors for transmission of highly pathogenic avian influenza A(H5N1) to humans, Cambodia, 2006-2010Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia.
P50
Q21144595-0AAD16FE-4B85-40C0-8D93-1D789FA9C13BQ24255260-4B578E35-E3A8-47A7-9FD0-E461916C79E7Q24286924-C3A1FF73-E2FF-4D7C-87C0-53B6F109DD97Q24811749-B0EE3FAC-F25B-4091-A3A0-7CC208E22160Q26800248-4C8DD2B3-C046-4390-ACAE-49DB43F2A8BDQ27674421-A2C00BFC-72E1-4009-BAE0-BD76E859C30EQ28248431-12A7816A-2447-410E-AF66-9F32CA17B814Q28384700-5372A2FA-D0B2-4CCD-9D25-9BCDC9E9B85BQ28394360-1BEA0029-6FA6-4C3B-849D-C04EDFD40B2CQ28657892-94E1F501-F5A4-456E-A1B7-120080EE3A32Q28660269-8F8A76F6-EC03-4C94-94A3-2BB98183C834Q28660530-1BEF6016-6701-4FFF-98B0-C8F289800454Q30223476-358BFC99-4B94-4F2D-90BA-668818D93775Q30234872-35B4F1AE-2925-4E76-BFC5-11EA4F61BD4EQ30251101-05CC68AC-8185-4D34-B04C-78BBDD8C475AQ30251101-78A66681-E639-4479-8AE2-78F5F6B7D85CQ30274816-FF6522F2-9C4E-4527-898F-5059362A75A9Q30355224-B1FA6539-6B20-4B53-A283-CB765D192592Q30390554-62D55BF8-280D-47C8-AFDC-3E4D2F8C4807Q30399171-CDA92C33-2DAC-4648-9DA0-C86E9D5A74EFQ30404745-A5874960-DEE8-4EAA-848E-AA9974D0F1E8Q30406967-2158F462-1A2A-471E-BB50-58189050711CQ30415530-C60A6D08-52C3-4080-96D6-692FA461199FQ30416214-514F5A0C-243E-48D6-A60B-5C9646C85DF7Q30416808-30585A12-9310-4D6B-BDC1-44BBB4ECC3C1Q30425378-E9D9A018-3C71-45AD-8059-B8CB14325A8BQ30428965-19295EAF-C9D5-4555-B015-E6E2237BBF9FQ30584295-312833FC-2936-456D-9688-E478EFFE38F3Q33489586-6D662553-C3AC-42AD-B051-8EE958B5FE72Q33883729-64039E93-9D5A-4FAB-A010-7B36A5E7E545Q34113112-F73B3799-8C75-47EA-AC08-47C1C9C6202AQ34653451-0E20B5C3-936E-4E33-9521-20A4B6916703Q35069335-D4D6CD2C-F491-4B55-89B3-F04954739CEFQ35118222-6FFAFFEE-F3F6-47CD-A06F-3F162683FE63Q35201785-21B531EB-AD6F-4051-9011-9C4A9456C384Q35364180-4C16C012-7E4F-4127-B3F7-34CEBDA2560EQ35646993-C98B53A9-BE2F-4A00-8204-9A762BD7BC2FQ35677865-684E1057-1E48-49A1-B047-B72817D39D5AQ35901999-488FEDCA-6A60-4C55-B4BF-133E543BA9BDQ36181571-8C0A2195-9242-48F3-8D25-4435136670A2
P50
description
American infectious disease epidemiologist
@en
US-amerikanische Epidemiologin auf dem Gebiet der Infektionskrankheiten
@de
name
Maria Van Kerkhove
@ast
Maria Van Kerkhove
@ca
Maria Van Kerkhove
@de
Maria Van Kerkhove
@en
Maria Van Kerkhove
@es
Maria Van Kerkhove
@eu
Maria Van Kerkhove
@fi
Maria Van Kerkhove
@id
Ван Керкхове, Мария
@ru
ماريا فان كيروف
@ar
type
label
Maria Van Kerkhove
@ast
Maria Van Kerkhove
@ca
Maria Van Kerkhove
@de
Maria Van Kerkhove
@en
Maria Van Kerkhove
@es
Maria Van Kerkhove
@eu
Maria Van Kerkhove
@fi
Maria Van Kerkhove
@id
Ван Керкхове, Мария
@ru
ماريا فان كيروف
@ar
altLabel
DeJoseph M
@en
DeJoseph M. R.
@en
DeJoseph M.
@en
DeJoseph MR
@en
DeJoseph Van Kerkhove M
@en
DeJoseph Van Kerkhove
@en
DeJoseph
@en
DeJoseph-Van Kerkhove M
@en
DeJoseph-Van Kerkhove
@en
M D Van Kerkhove
@en
prefLabel
Maria Van Kerkhove
@ast
Maria Van Kerkhove
@ca
Maria Van Kerkhove
@de
Maria Van Kerkhove
@en
Maria Van Kerkhove
@es
Maria Van Kerkhove
@eu
Maria Van Kerkhove
@fi
Maria Van Kerkhove
@id
Ван Керкхове, Мария
@ru
ماريا فان كيروف
@ar
P108
P69
P227
P2671
P106
P108
P1477
Maria Rosanne DeJoseph
@en
P19
P2002
mvankerkhove
P2013
maria.vankerkhove
P2031
2006-01-01T00:00:00Z
P21
P214
700149066653565602235
P227
1128243881
P2671
/g/11ddwyb2sy
P31
P496
0000-0002-6135-0018
P569
1977-02-20T00:00:00Z